Sabra Healthcare REIT Target Price

Analysts' average 12-month price target for Sabra Healthcare REIT is $22.

Get informed when a big investor buys or sells

+ Follow

Share Price

$20.78

Average Target Price

$22.00

5.9% upside

10 analysts in the last 4 months

High: $25 | Low: $19

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-31	Mizuho Securities	$21	1.1% upside
2026-08-31	BarclaysRichard Hightower	$23	10.7% upside
2026-07-22	UBS	$25	20.3% upside
2026-07-22	Robert W. BairdWesley Golladay	$23	10.7% upside
2026-07-08	Truist Financial	$22	5.9% upside
2026-07-07	Barclays	$21	1.1% upside
2026-06-18	UBS	$19	8.6% downside
2026-05-21	Scotiabank	$22	5.9% upside
2026-05-13	UBSMichael Goldsmith	$22	5.9% upside
2026-05-11	Cantor FitzgeraldRichard Anderson	$22	5.9% upside
2026-02-19	UBSMichael Goldsmith	$21	1.1% upside
2026-02-17	Cantor FitzgeraldRichard Anderson	$21	1.1% upside
2026-01-20	Truist FinancialMichael Lewis	$21	1.1% upside
2025-12-15	JefferiesJoe Dickstein	$22	5.9% upside
2025-11-25	Wells Fargo	$21	1.1% upside
2025-10-21	Wells Fargo	$20	3.8% downside
2025-10-17	National Bank	$22	5.9% upside
2025-10-01	Cantor FitzgeraldRichard Anderson	$20	3.8% downside
2025-09-02	Truist Financial	$20	3.8% downside
2024-09-12	CitigroupNicholas Joseph	$20	3.8% downside
2024-09-03	Truist FinancialMichael Lewis	$18	13.4% downside
2024-06-21	Robert W. BairdDavid Rodgers	$16	23% downside
2024-05-15	ScotiabankNicholas Yulico	$15	27.8% downside
2023-05-31	Credit SuisseOmotayo Okusanya	$13	37.4% downside
2021-12-27	Truist FinancialMichael R Lewis	$16	23% downside
2021-08-24	JefferiesJonathan Petersen	$19	8.6% downside
2021-05-04	Capital One FinancialDaniel Bernstein	$20	3.8% downside

Sabra Healthcare REIT (SBRA) FAQ

Sabra Healthcare REIT's target price stands at $22. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $22 for SBRA implies 5.9% upside versus today's price ($20.78). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how Sabra Healthcare REIT's target price evolved across reporting periods, while the comparison chart places SBRA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Finance, target price is commonly used to spot outliers. Sabra Healthcare REIT's reading of $22 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.